Clearpoint Neuro Inc at Stifel Healthcare Conference (Virtual) Transcript
Good morning, everybody. My name is Matt Blackman, I'm a member of the Stifel medtech research team. Thanks for joining us for our session with ClearPoint Neuro. Just by of way of quick background, ClearPoint Neuro is, it's roughly a $400 billion market cap company with a really interesting platform technology that provides stereotactic navigation, which facilitates minimally invasive surgical procedures in the brain under MRI guidance. Current applications of the system include electrode lead placement, placement of catheters and biopsy.
And the platform is also being used for the delivery of biologics, gene therapy, stem cell therapies to the brain. It's FDA cleared, CE marked. There are over 60 active clinical sites across the U.S., Canada and Europe. So a really exciting technology that I think everyone will look forward to hearing about. It's our pleasure to have Joe Burnett, the President and CEO; Danilo DâAlessandro, Chief Financial Officer. They're here to walk us through, as I said, the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
